As of 2024-12-13, the Relative Valuation of Transgene SA (TNG.PA) is (2.43) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.72 EUR, the upside of Transgene SA based on Relative Valuation is -439.9%.
The range of the Relative Valuation is (2.10) - (3.51) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.8x - 26.6x | 14.1x |
| Forward P/E multiples | 13.0x - 21.8x | 16.1x |
| Fair Price | (2.10) - (3.51) | (2.43) |
| Upside | -393.1% - -590.7% | -439.9% |
| Date | P/E |
| 2024-12-03 | -4.52 |
| 2024-12-02 | -4.43 |
| 2024-11-29 | -4.55 |
| 2024-11-28 | -4.59 |
| 2024-11-27 | -4.75 |
| 2024-11-26 | -4.73 |
| 2024-11-25 | -4.80 |
| 2024-11-22 | -4.89 |
| 2024-11-21 | -4.85 |
| 2024-11-20 | -4.83 |
| 2024-11-19 | -4.81 |
| 2024-11-18 | -4.81 |
| 2024-11-15 | -4.99 |
| 2024-11-14 | -5.11 |
| 2024-11-13 | -5.30 |
| 2024-11-12 | -5.40 |
| 2024-11-11 | -5.39 |
| 2024-11-08 | -5.40 |
| 2024-11-07 | -5.83 |
| 2024-11-06 | -5.72 |
| 2024-11-05 | -5.68 |
| 2024-11-04 | -5.72 |
| 2024-11-01 | -5.63 |
| 2024-10-31 | -5.65 |
| 2024-10-30 | -5.57 |
| 2024-10-29 | -5.22 |
| 2024-10-28 | -5.27 |
| 2024-10-25 | -5.52 |
| 2024-10-24 | -5.78 |
| 2024-10-23 | -6.15 |
| 2024-10-22 | -6.14 |
| 2024-10-21 | -6.20 |
| 2024-10-18 | -6.23 |
| 2024-10-17 | -6.46 |
| 2024-10-16 | -6.27 |
| 2024-10-15 | -6.17 |
| 2024-10-14 | -6.25 |
| 2024-10-11 | -7.23 |
| 2024-10-10 | -7.27 |
| 2024-10-09 | -7.38 |
| 2024-10-08 | -7.33 |
| 2024-10-07 | -6.86 |
| 2024-10-04 | -6.82 |
| 2024-10-03 | -6.91 |
| 2024-10-02 | -6.78 |
| 2024-10-01 | -7.07 |
| 2024-09-30 | -6.89 |
| 2024-09-27 | -6.80 |
| 2024-09-26 | -6.76 |
| 2024-09-25 | -6.53 |